Cargando…

Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma

BACKGROUND: Cholangiocellular cancers account for about 10-15% of primary liver cancers. Prognosis is poor, with expected survival of less than 5% at five-year. CASE PRESENTATION: The case described shows remission of a disseminated cholangiocellular carcinoma (focal changes in liver, metastases to...

Descripción completa

Detalles Bibliográficos
Autores principales: Slupski, Maciej W, Szczylik, Cezary, Jasinski, Milosz K
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839091/
https://www.ncbi.nlm.nih.gov/pubmed/17376238
http://dx.doi.org/10.1186/1477-7819-5-36
_version_ 1782132848918003712
author Slupski, Maciej W
Szczylik, Cezary
Jasinski, Milosz K
author_facet Slupski, Maciej W
Szczylik, Cezary
Jasinski, Milosz K
author_sort Slupski, Maciej W
collection PubMed
description BACKGROUND: Cholangiocellular cancers account for about 10-15% of primary liver cancers. Prognosis is poor, with expected survival of less than 5% at five-year. CASE PRESENTATION: The case described shows remission of a disseminated cholangiocellular carcinoma (focal changes in liver, metastases to lungs) after neoadjuvant chemotherapy. The initial diagnosis was based on ultrasound examination and confirmed with computer tomography. Tumour biopsy and histopathological examination revealed cholangiocellular carcinoma. The patient underwent chemotherapy. After remission of lesions in lungs and reduction/regression of tumours in liver to one focal change, right lobe liver resection was performed. The histopathological examination did not reveal any viable carcinoma cells, only necrotic tissues in place of the primary tumour as well as in local portal vein branches was seen. Thirty months after the operation the patient is in a good overall condition and no recurrence has been observed. CONCLUSION: Appropriate neoadjuvant chemotherapy may allow radical resection in a previously unresectable cholangiocellular cancer.
format Text
id pubmed-1839091
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-18390912007-03-30 Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma Slupski, Maciej W Szczylik, Cezary Jasinski, Milosz K World J Surg Oncol Technical Innovations BACKGROUND: Cholangiocellular cancers account for about 10-15% of primary liver cancers. Prognosis is poor, with expected survival of less than 5% at five-year. CASE PRESENTATION: The case described shows remission of a disseminated cholangiocellular carcinoma (focal changes in liver, metastases to lungs) after neoadjuvant chemotherapy. The initial diagnosis was based on ultrasound examination and confirmed with computer tomography. Tumour biopsy and histopathological examination revealed cholangiocellular carcinoma. The patient underwent chemotherapy. After remission of lesions in lungs and reduction/regression of tumours in liver to one focal change, right lobe liver resection was performed. The histopathological examination did not reveal any viable carcinoma cells, only necrotic tissues in place of the primary tumour as well as in local portal vein branches was seen. Thirty months after the operation the patient is in a good overall condition and no recurrence has been observed. CONCLUSION: Appropriate neoadjuvant chemotherapy may allow radical resection in a previously unresectable cholangiocellular cancer. BioMed Central 2007-03-21 /pmc/articles/PMC1839091/ /pubmed/17376238 http://dx.doi.org/10.1186/1477-7819-5-36 Text en Copyright © 2007 Slupski et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Technical Innovations
Slupski, Maciej W
Szczylik, Cezary
Jasinski, Milosz K
Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
title Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
title_full Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
title_fullStr Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
title_full_unstemmed Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
title_short Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
title_sort unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma
topic Technical Innovations
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839091/
https://www.ncbi.nlm.nih.gov/pubmed/17376238
http://dx.doi.org/10.1186/1477-7819-5-36
work_keys_str_mv AT slupskimaciejw unexpectedresponsetosystemicchemotherapyincaseofprimarilynonresectableadvanceddisseminatedintrahepaticcholangiocarcinoma
AT szczylikcezary unexpectedresponsetosystemicchemotherapyincaseofprimarilynonresectableadvanceddisseminatedintrahepaticcholangiocarcinoma
AT jasinskimiloszk unexpectedresponsetosystemicchemotherapyincaseofprimarilynonresectableadvanceddisseminatedintrahepaticcholangiocarcinoma